Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CONVERGENCE MEDICAL : revenue, balance sheet and financial ratios

CONVERGENCE MEDICAL is a French company founded 9 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in LES ABYMES (97139), this company of category PME shows in 2025 a net income positive of 364 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CONVERGENCE MEDICAL (SIREN 820903474)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 364 301 € 892 386 € 964 425 € 235 704 € 17 961 € 18 930 € 28 427 € 127 904 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, CONVERGENCE MEDICAL generates positive net income of 364 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 128 k€ -> 364 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

364 301 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 59%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

58.614%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.655%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

66.0%

Solvency indicators evolution
CONVERGENCE MEDICAL

Sector positioning

Debt ratio
58.61 2025
2023
2024
2025
Q1: 0.0
Med: 3.67
Q3: 28.55
Average +18 pts over 3 years

In 2025, the debt ratio of CONVERGENCE MEDICAL (58.61) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.66% 2025
2023
2024
2025
Q1: 26.28%
Med: 43.48%
Q3: 62.04%
Average -27 pts over 3 years

In 2025, the financial autonomy of CONVERGENCE MEDICAL (30.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 117.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

117.971

Liquidity indicators evolution
CONVERGENCE MEDICAL

Sector positioning

Liquidity ratio
117.97 2025
2023
2024
2025
Q1: 147.44
Med: 215.05
Q3: 310.05
Watch -14 pts over 3 years

In 2025, the liquidity ratio of CONVERGENCE MEDICAL (117.97) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of CONVERGENCE MEDICAL in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of CONVERGENCE MEDICAL is estimated at 299 278 € (range 113 907€ - 1 092 928€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
124 transactions
113k€ 299k€ 1092k€
299 278 € Range: 113 907€ - 1 092 928€
NAF 5 all-time

Valuation method used

Net Income Multiple
364 301 € × 0.8x = 299 279 €
Range: 113 908€ - 1 092 929€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare CONVERGENCE MEDICAL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about CONVERGENCE MEDICAL

What is the revenue of CONVERGENCE MEDICAL ?

The revenue of CONVERGENCE MEDICAL is not publicly disclosed (confidential accounts filed with INPI).

Is CONVERGENCE MEDICAL profitable?

Yes, CONVERGENCE MEDICAL generated a net profit of 364 k€ in 2025.

Where is the headquarters of CONVERGENCE MEDICAL ?

The headquarters of CONVERGENCE MEDICAL is located in LES ABYMES (97139), in the department Guadeloupe.

Where to find the tax return of CONVERGENCE MEDICAL ?

The tax return of CONVERGENCE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CONVERGENCE MEDICAL operate?

CONVERGENCE MEDICAL operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.